Live Breaking News & Updates on Program In Solid Tumors

Stay updated with breaking news from Program in solid tumors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

ASCO 2024 oral presentation of darovasertib neoadjuvant UM Phase 2 investigator-sponsored trial on June 3rd, and targeting neoadjuvant UM update in over 30. ....

United States , New South Wales , Anthony Joshua , Darrin Beaupre , Werner Helicase , Yujiros Hata , Andres Ruiz Briseno , Program In Solid Tumors , Merck Sharp Dohme , Exchange Commission , International Business Gmb , Us Food Drug Administration , Biosciences Inc , Merck Co Inc , Program In Tumors , Kinghorn Cancer Centre , American Society Of Clinical Oncology , Head Department Of Medical Oncology , Chief Executive Officer , Chief Medical Officer , Recent Key , Clinical Oncology , Business Gmbh , Programs Update , Drug Administration , Fast Track ,

IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Targeting two independent Phase 2 clinical efficacy updates for darovasertib in neoadjuvant uveal melanoma in mid-2024, including from the Phase 2 IST and Phase 2 company-sponsored studyTargeting. ....

New South Wales , United Kingdom , Werner Helicase , Trodelvy Sacituzumab Govitecan Hziy , Anthony Joshua , Andres Ruiz Briseno , Yujiros Hata , Darrin Beaupre , Exchange Commission , Darovasertib Program In Tumors , Program In Solid Tumors , European Society For Medical Oncology Congress , Cancer Research United Kingdom , Gilead Sciences , Head Department Of Medical Oncology , Kinghorn Cancer Centre , University Of Manchester , Us Food Drug Administration , Program In Tumors , Biosciences Inc , Uveal Melanoma , Chief Executive Officer , Chief Medical Officer , Proffered Paper , Medical Oncology , Programs Update ,